EGFR and breast cancer: The impact of EGFR and ERBB2 SNPs warrant further study in a larger cohort of HER2-positive BC patient samples, to ascertain the impact of common ERBB2 and EGFR SNPs on trastuzumab response and survival in HER2-positive BC.